Isbufylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161533This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C11H16N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9C8Z5F38D0, chemically known as 3,7-dihydro-1,3-dimethyl-7-(2-methylpropyl)-1h-purine-2,6-dione but generally known as isbufylline, which bears US NIH Compound Identifier 65681. European Medicines Agency schedules Isbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08308MIG. The term ISBUFYLLINE is an International Non-Proprietary Name. ISBUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isbufylline under HS 29395900 and SITC 54145. As of Q4 2014, ISBUFYLLINE remains the US FDA Preferred Term for this commodity. Isbufylline bears US NLM identifiers UMLS ID C0043937 and NCI Concept Code C65970. SMILES: CC(C)CN1C=NC2=C1C(=O)N(C(=O)N2C)C.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.